Literature DB >> 19597491

A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke.

Daniel F Gudbjartsson1, Hilma Holm, Solveig Gretarsdottir, Gudmar Thorleifsson, G Bragi Walters, Gudmundur Thorgeirsson, Jeffrey Gulcher, Ellisiv B Mathiesen, Inger Njølstad, Audhild Nyrnes, Tom Wilsgaard, Erin M Hald, Kristian Hveem, Camilla Stoltenberg, Gayle Kucera, Tanya Stubblefield, Shannon Carter, Dan Roden, Maggie C Y Ng, Larry Baum, Wing Yee So, Ka Sing Wong, Juliana C N Chan, Christian Gieger, H-Erich Wichmann, Andreas Gschwendtner, Martin Dichgans, Gregor Kuhlenbäumer, Klaus Berger, E Bernd Ringelstein, Steve Bevan, Hugh S Markus, Konstantinos Kostulas, Jan Hillert, Sigurlaug Sveinbjörnsdóttir, Einar M Valdimarsson, Maja-Lisa Løchen, Ronald C W Ma, Dawood Darbar, Augustine Kong, David O Arnar, Unnur Thorsteinsdottir, Kari Stefansson.   

Abstract

We expanded our genome-wide association study on atrial fibrillation (AF) in Iceland, which previously identified risk variants on 4q25, and tested the most significant associations in samples from Iceland, Norway and the United States. A variant in the ZFHX3 gene on chromosome 16q22, rs7193343-T, associated significantly with AF (odds ratio OR = 1.21, P = 1.4 x 10(-10)). This variant also associated with ischemic stroke (OR = 1.11, P = 0.00054) and cardioembolic stroke (OR = 1.22, P = 0.00021) in a combined analysis of five stroke samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597491      PMCID: PMC2740741          DOI: 10.1038/ng.417

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  6 in total

1.  Positive and negative regulation of myogenic differentiation of C2C12 cells by isoforms of the multiple homeodomain zinc finger transcription factor ATBF1.

Authors:  F B Berry; Y Miura; K Mihara; P Kaspar; N Sakata; T Hashimoto-Tamaoki; T Tamaoki
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

Review 2.  Antithrombotic treatment in atrial fibrillation.

Authors:  G Y H Lip; C J Boos
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

3.  A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers.

Authors:  T Morinaga; H Yasuda; T Hashimoto; K Higashio; T Tamaoki
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

4.  Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke.

Authors:  Solveig Gretarsdottir; Gudmar Thorleifsson; Andrei Manolescu; Unnur Styrkarsdottir; Anna Helgadottir; Andreas Gschwendtner; Konstantinos Kostulas; Gregor Kuhlenbäumer; Steve Bevan; Thorbjorg Jonsdottir; Hjordis Bjarnason; Jona Saemundsdottir; Stefan Palsson; David O Arnar; Hilma Holm; Gudmundur Thorgeirsson; Einar Mar Valdimarsson; Sigurlaug Sveinbjörnsdottir; Christian Gieger; Klaus Berger; H-Erich Wichmann; Jan Hillert; Hugh Markus; Jeffrey Robert Gulcher; E Bernd Ringelstein; Augustine Kong; Martin Dichgans; Daniel Fannar Gudbjartsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

5.  Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Thomas J Wang; Eric P Leip; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Ralph B D'Agostino; Joseph M Massaro; Alexa Beiser; Philip A Wolf; Emelia J Benjamin
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

6.  Variants conferring risk of atrial fibrillation on chromosome 4q25.

Authors:  Daniel F Gudbjartsson; David O Arnar; Anna Helgadottir; Solveig Gretarsdottir; Hilma Holm; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Adam Baker; Gudmar Thorleifsson; Kristleifur Kristjansson; Arnar Palsson; Thorarinn Blondal; Patrick Sulem; Valgerdur M Backman; Gudmundur A Hardarson; Ebba Palsdottir; Agnar Helgason; Runa Sigurjonsdottir; Jon T Sverrisson; Konstantinos Kostulas; Maggie C Y Ng; Larry Baum; Wing Yee So; Ka Sing Wong; Juliana C N Chan; Karen L Furie; Steven M Greenberg; Michelle Sale; Peter Kelly; Calum A MacRae; Eric E Smith; Jonathan Rosand; Jan Hillert; Ronald C W Ma; Patrick T Ellinor; Gudmundur Thorgeirsson; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nature       Date:  2007-07-01       Impact factor: 49.962

  6 in total
  210 in total

1.  Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification.

Authors:  Jun Wang; Elzbieta Klysik; Subeena Sood; Randy L Johnson; Xander H T Wehrens; James F Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Repolarization recipes for atrial fibrillation: beyond single channel variants.

Authors:  Dawood Darbar; Babar Parvez; Robert Abraham
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

3.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

4.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.

Authors:  Babar Parvez; Joseph Vaglio; Shane Rowan; Raafia Muhammad; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

5.  The environmental epidemiology of atrial arrhythmogenesis.

Authors:  Eric A Whitsel; Christy L Avery
Journal:  J Epidemiol Community Health       Date:  2010-05-24       Impact factor: 3.710

6.  Heterozygous deletion of Atbf1 by the Cre-loxP system in mice causes preweaning mortality.

Authors:  Xiaodong Sun; Xiaoying Fu; Jie Li; Changsheng Xing; David W Martin; Helen Heju Zhang; Zhengjia Chen; Jin-Tang Dong
Journal:  Genesis       Date:  2012-06-21       Impact factor: 2.487

7.  Can polymorphisms predict response to antiarrhythmic drugs in atrial fibrillation?

Authors:  James P Daubert; Geoffrey S Pitt
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

8.  Association between familial atrial fibrillation and risk of new-onset atrial fibrillation.

Authors:  Steven A Lubitz; Xiaoyan Yin; João D Fontes; Jared W Magnani; Michiel Rienstra; Manju Pai; Mark L Villalon; Ramachandran S Vasan; Michael J Pencina; Daniel Levy; Martin G Larson; Patrick T Ellinor; Emelia J Benjamin
Journal:  JAMA       Date:  2010-11-13       Impact factor: 56.272

Review 9.  Unravelling the human genome-phenome relationship using phenome-wide association studies.

Authors:  William S Bush; Matthew T Oetjens; Dana C Crawford
Journal:  Nat Rev Genet       Date:  2016-02-15       Impact factor: 53.242

10.  Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL).

Authors:  Gerald S Bloomfield; Tecla M Temu; Constantine O Akwanalo; Peng-Sheng Chen; Wilfred Emonyi; Susan R Heckbert; Myra M Koech; Imran Manji; Changyu Shen; Matteo Vatta; Eric J Velazquez; Jennifer Wessel; Sylvester Kimaiyo; Thomas S Inui
Journal:  Am Heart J       Date:  2015-06-14       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.